Efficacy of diammonium glycyrrhizinate combined with vitamin C for treating hospitalized 2 COVID-19 patients: a retrospective, observational study 3 4
Ruoming Tan, Xiaogang Xiang, Wei Chen, Zhitao Yang, Weiguo Hu, Hongping Qu, Liu
doi:10.1093/qjmed/hcab184/6329274
Aims: To observe the effect of combination treatment of giammonium glycyrrhizinate and vitamin 36 C (DV)on the prognoses of patients with COVID-19. 37 Methods: This retrospective observational study recruited 207 COVID-19 patients from Tongji 38 Hospital,patients were assigned to DV and non-DV groups on the basis of the DV treatment. To 39 make the results more credible, a propensity-score matching (PSM) approach was adopted at a 1:3 40 ratio to determine the participants. Logistic analysis was used to assess the effect of DV therapy in 41 the progress of COVID-19. 42 Results: In the DV group, the new onset incidence rate of acute respiratory distress syndrome 43 (ARDS) after admission was clearly lower than that in the non-DV group (DV vs non-DV groups, 44 15.2% vs 35.7%; P=0.002). Compared with the non-DV group, the DV group showed fewer new 45 onset of complications (such as ARDS, acute liver injury and acute myocardial injury) (DV vs non-46 DV groups,19.6% vs 46.1%; P=0.000). Moreover, DG+VC may help to recover the count of NK 47 cells and decrease the level of sIL-2R. 48 Conclusions: DG+VC might be a promising candidate for preventing the deterioration of COVID-49 19 patients, which is worthy to be studied in large and perspective cohort. 50
Authors' contributions
300 LJL and HPQ contributed to study concept and design. RMT and XGX contributed to the literature
References
Biancatelli, Mmarik, The antiviral properties of vitamin C, Expert Rev 333 Anti Infect Ther
Chen, Hu, Hood, Zhang, Zhang et al., A Novel Combination of Vitamin C, 376 Curcumin and Glycyrrhizic Acid Potentially Regulates Immune and Inflammatory Response 377 Associated with Coronavirus Infections: A Perspective from System Biology Analysis, Nutrients
Chen, Zhou, Dong, Qu, Gong et al., Epidemiological and clinical 365 characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive 366 study, Lancet
Chiscano-Camon, Ruiz-Rodriguez, Ruiz-Sanmartin, Oferrer, Vitamin C levels 368 in patients with SARS-CoV-2-associated acute respiratory distress syndrome, Crit Care
Cvergoten, Glycyrrhizin: An alternative drug for the treatment of COVID-19 infection 327 and the associated respiratory syndrome?, Pharmacol Ther
Ding, Deng, Ding, Ye, Shuang, Glycyrrhetinic acid and its derivatives as 373 potential alternative medicine to relieve symptoms in nonhospitalized COVID-19 patients, J Med
Du, Liang, Yang, Wang, Cao et al., SARS-CoV-2 infection complicated 362 by inflammatory syndrome. Could high-dose human immunoglobulin for intravenous use (IVIG) 363 be beneficial?, Autoimmun Rev
Force, Ranieri, Rubenfeld, Thompson, Ferguson et al., Acute respiratory distress syndrome: the Berlin Definition, JAMA
Gabarre, Dumas, Dupont, Darmon, Ezafrani, Acute kidney injury in 348 critically ill patients with COVID-19, Intensive Care Med
Hiedra, Lo, Elbashabsheh, Gul, Wright et al., The use of IV vitamin 371 C for patients with COVID-19: a case series, Expert Rev Anti Infect Ther
Holford, Carr, Jovic, Ali, Whitaker et al., Vitamin C-An Adjunctive
Huang, Wang, Li, Ren, Zhao et al., Clinical features of patients infected with 320 2019 novel coronavirus in Wuhan, China, Lancet
Huang, Wang, Li, Ren, Zhao et al., Clinical features of patients infected with 343 2019 novel coronavirus in Wuhan, China, Lancet
Kwo, Smlim, ACG Clinical Guideline: Evaluation of Abnormal Liver 341 Chemistries, Am J Gastroenterol
Li, Sun, Liu, Natural products in licorice for the therapy of liver diseases: Progress and 329 future opportunities, Pharmacol Res
Li, Wu, Li, Liang, Kpchen, Integrative pharmacological mechanism of vitamin 322 C combined with glycyrrhizic acid against COVID-19: findings of bioinformatics analyses, Bioinform
Luo, Liu, Li, Pharmacological perspective: glycyrrhizin may be an efficacious therapeutic 325 agent for COVID-19, Int J Antimicrob Agents
Riva, Yuan, Yin, Martin-Sancho, Matsunaga et al., SARS-CoV-2 was associated with organ dysfunction such as ARDS, acute heart injury, acute 238 kidney injury, shock and acute liver injury,significant cases progressed rapidly to severe forms 239
Singer, Deutschman, Seymour, Shankar-Hari, Annane et al., The 345 Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3), JAMA
Wu, Chen, Cai, Xia, Zhou et al., Risk Factors Associated With Acute 350 Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia 351 in Wuhan, China, JAMA Intern Med
Zhang, Rao, Li, Zhu, Liu et al., Harm of IV High-Dose 337 Vitamin C Therapy in Adult Patients: A Scoping Review, Ann Intensive Care